Originally posted by novacs4me
I've been browsing through the patent, and it seems all related to H5N1, not to H1N1. Did I miss something?
Medimmune holds a patent for
reverse genetic recombination in regards to H1N1
MedImmune
MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of
AstraZeneca in 2007.
Note : MedImmune CEO quits AstraZeneca, 1 year after deal :
www.reuters.com...
Company President : Tony Zook
AstraZeneca
Is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had
been part of
Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993
Louis Schweitzer, Chairman
David R. Brennan, CEO
Imperial Chemical Industries
Imperial Chemical Industries (ICI) is a British chemical subsidiary of a Dutch conglomerate and one of the largest chemical producers in the world.
Formed by 1926 merger of four British chemical companies -- Nobel Industries (founded by Alfred Nobel); Brunner, Mond and Co.; United Alkali Co.; and
British Dyestuffs Corporation). ICI Pharmaceuticals spun off as Zeneca in 1994.
Peter Ellwood (Chairman)
John McAdam (CEO)
[edit on 12-9-2009 by new_guy_in_town]